Prostate needle biopsy processing: a survey of laboratory practice across Europe
暂无分享,去创建一个
D. Berney | G. Kristiansen | M. Varma | L. Egevad | F. Algaba | E. Compérat | D. Griffiths | R. Montironi | P. Camparo | A. López-Beltran
[1] Lars Egevad,et al. The European Network of Uropathology: a novel mechanism for communication between pathologists. , 2009, Analytical and quantitative cytology and histology.
[2] R. Dhir. Aberrant Diffuse Expression of p63 in Adenocarcinoma of the Prostate on Needle Biopsy and Radical Prostatectomy: Report of 21 Cases , 2009 .
[3] D. Berney,et al. Variations in the processing of prostatic needle cores in the UK; what is safe? , 2003, Journal of clinical pathology.
[4] T. H. van der Kwast,et al. Guidelines for processing and reporting of prostatic needle biopsies , 2003, Journal of clinical pathology.
[5] J. Epstein,et al. Use of intervening unstained slides for immunohistochemical stains for high molecular weight cytokeratin on prostate needle biopsies. , 1999, The American journal of surgical pathology.
[6] D. Brat,et al. How often are diagnostic features missed with less extensive histologic sampling of prostate needle biopsy specimens? , 1999, The American journal of surgical pathology.
[7] W. Allsbrook,et al. Needle biopsies of the prostate: what constitutes adequate histologic sampling? , 1998, Archives of pathology & laboratory medicine.
[8] P. Humphrey,et al. Diagnostic effect of complete histologic sampling of prostate needle biopsy specimens. , 1998, American journal of clinical pathology.
[9] A. Renshaw. Adequate tissue sampling of prostate core needle biopsies. , 1997, American journal of clinical pathology.
[10] D. Wood,et al. Single focus of adenocarcinoma in the prostate biopsy specimen is not predictive of the pathologic stage of disease. , 1996, Urology.